ORGANON & COMPANYORGANON & COMPANYORGANON & COMPANY

ORGANON & COMPANY

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.16 B‬EUR
‪926.85 M‬EUR
‪5.67 B‬EUR
‪256.66 M‬
Beta (1Y)
0.87

About Organon & Co.

CEO
Kevin Ali
Headquarters
Jersey City
Employees (FY)
‪10 K‬
Founded
2020
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 7XP is 20.08 EUR — it has increased by 0.45% in the past 24 hours. Watch ORGANON & COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ORGANON & COMPANY stocks are traded under the ticker 7XP.
7XP stock has risen by 4.42% compared to the previous week, the month change is a 19.38% rise, over the last year ORGANON & COMPANY has showed a 6.75% increase.
We've gathered analysts' opinions on ORGANON & COMPANY future price: according to them, 7XP price has a max estimate of 27.88 EUR and a min estimate of 14.87 EUR. Watch 7XP chart and read a more detailed ORGANON & COMPANY stock forecast: see what analysts think of ORGANON & COMPANY and suggest that you do with its stocks.
7XP reached its all-time high on May 26, 2022 with the price of 36.52 EUR, and its all-time low was 10.03 EUR and was reached on Dec 6, 2023. View more price dynamics on 7XP chart.
See other stocks reaching their highest and lowest prices.
7XP stock is 1.41% volatile and has beta coefficient of 0.87. Track ORGANON & COMPANY stock price on the chart and check out the list of the most volatile stocks — is ORGANON & COMPANY there?
Today ORGANON & COMPANY has the market capitalization of ‪5.16 B‬, it has increased by 3.37% over the last week.
Yes, you can track ORGANON & COMPANY financials in yearly and quarterly reports right on TradingView.
ORGANON & COMPANY is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
7XP earnings for the last quarter are 1.13 EUR per share, whereas the estimation was 0.91 EUR resulting in a 24.76% surprise. The estimated earnings for the next quarter are 1.07 EUR per share. See more details about ORGANON & COMPANY earnings.
ORGANON & COMPANY revenue for the last quarter amounts to ‪1.50 B‬ EUR despite the estimated figure of ‪1.45 B‬ EUR. In the next quarter revenue is expected to reach ‪1.51 B‬ EUR.
7XP net income for the last quarter is ‪186.28 M‬ EUR, while the quarter before that showed ‪494.68 M‬ EUR of net income which accounts for −62.34% change. Track more ORGANON & COMPANY financial stats to get the full picture.
Yes, 7XP dividends are paid quarterly. The last dividend per share was 0.26 EUR. As of today, Dividend Yield (TTM)% is 5.14%. Tracking ORGANON & COMPANY dividends might help you take more informed decisions.
ORGANON & COMPANY dividend yield was 7.77% in 2023, and payout ratio reached 28.06%. The year before the numbers were 4.01% and 31.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 22, 2024, the company has ‪10.00 K‬ employees. See our rating of the largest employees — is ORGANON & COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANON & COMPANY EBITDA is ‪1.47 B‬ EUR, and current EBITDA margin is 24.96%. See more stats in ORGANON & COMPANY financial statements.
Like other stocks, 7XP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANON & COMPANY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORGANON & COMPANY technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORGANON & COMPANY stock shows the buy signal. See more of ORGANON & COMPANY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.